Steffen Boettcher

University Hospital of Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (11)

Annika Hausmann

Københavns Universitet

DENMARK

View details

Hitoshi Takizawa

Vice Director and Professor

Kumamoto University

JAPAN

View details

Cesar Nombela-Arrieta

Assistant Professor

University of Zurich

SWITZERLAND

View details

Markus G. Manz

SWITZERLAND

View details

Bing Carter

professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Koichi Takahashi

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Lauren Ostermann

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Warren Fiskus

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Emma Slack

Professor at ETH Zürich

ETH Zürich

SWITZERLAND

View details

Christian Matthias Wilk

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Wolf-Dietrich Hardt

Professor of Microbiology

Eidgenössische Technische Hochschule Zürich

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Steffen Boettcher

Research Interests

Explore related searches

Contact this professor

Articles (10)

Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics

Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics

Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1

Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling

IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice

Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)

<i>TP53</i> mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

CXCL12-abundant reticular cells are the major source of IL-6 upon LPS stimulation and thereby regulate hematopoiesis

Clonal hematopoiesis in hematopoietic stem cell transplantation.

Collaborators (11)

Annika Hausmann

Hitoshi Takizawa

Cesar Nombela-Arrieta

Markus G. Manz

Bing Carter

Koichi Takahashi

Lauren Ostermann

Warren Fiskus

Emma Slack

Christian Matthias Wilk

Wolf-Dietrich Hardt

Make your next move.